vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Core Scientific, Inc. (CORZ). Click either name above to swap in a different company.

Core Scientific, Inc. is the larger business by last-quarter revenue ($79.8M vs $45.1M, roughly 1.8× Amarin Corp plc). Core Scientific, Inc. runs the higher net margin — 268.5% vs -23.3%, a 291.8% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs -16.0%). Over the past eight quarters, Amarin Corp plc's revenue compounded faster (-18.3% CAGR vs -33.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.

AMRN vs CORZ — Head-to-Head

Bigger by revenue
CORZ
CORZ
1.8× larger
CORZ
$79.8M
$45.1M
AMRN
Growing faster (revenue YoY)
AMRN
AMRN
+23.0% gap
AMRN
7.0%
-16.0%
CORZ
Higher net margin
CORZ
CORZ
291.8% more per $
CORZ
268.5%
-23.3%
AMRN
Faster 2-yr revenue CAGR
AMRN
AMRN
Annualised
AMRN
-18.3%
-33.3%
CORZ

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
CORZ
CORZ
Revenue
$45.1M
$79.8M
Net Profit
$-10.5M
$214.2M
Gross Margin
26.0%
Operating Margin
35.5%
-149.5%
Net Margin
-23.3%
268.5%
Revenue YoY
7.0%
-16.0%
Net Profit YoY
33.0%
180.6%
EPS (diluted)
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
CORZ
CORZ
Q1 26
$45.1M
Q4 25
$49.2M
$79.8M
Q3 25
$49.7M
$81.1M
Q2 25
$72.7M
$78.6M
Q1 25
$42.0M
$79.5M
Q4 24
$62.3M
$94.9M
Q3 24
$42.3M
$95.4M
Q2 24
$67.5M
$141.1M
Net Profit
AMRN
AMRN
CORZ
CORZ
Q1 26
$-10.5M
Q4 25
$-1.2M
$214.2M
Q3 25
$-7.7M
$-144.0M
Q2 25
$-14.1M
$-936.8M
Q1 25
$-15.7M
$576.3M
Q4 24
$-48.6M
$-265.5M
Q3 24
$-25.1M
$-455.3M
Q2 24
$1.5M
$-902.2M
Gross Margin
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
47.1%
26.0%
Q3 25
44.7%
4.8%
Q2 25
69.2%
6.4%
Q1 25
59.8%
10.3%
Q4 24
-15.4%
5.0%
Q3 24
38.5%
-0.2%
Q2 24
63.4%
27.5%
Operating Margin
AMRN
AMRN
CORZ
CORZ
Q1 26
35.5%
Q4 25
-12.9%
-149.5%
Q3 25
-22.4%
-67.6%
Q2 25
-22.0%
-33.4%
Q1 25
-39.9%
-59.1%
Q4 24
-84.3%
-41.9%
Q3 24
-59.5%
-43.2%
Q2 24
-0.8%
-64.3%
Net Margin
AMRN
AMRN
CORZ
CORZ
Q1 26
-23.3%
Q4 25
-2.5%
268.5%
Q3 25
-15.6%
-177.6%
Q2 25
-19.4%
-1191.4%
Q1 25
-37.4%
724.6%
Q4 24
-78.0%
-279.7%
Q3 24
-59.4%
-477.4%
Q2 24
2.3%
-639.4%
EPS (diluted)
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
$0.00
$-1.63
Q3 25
$-0.02
$-0.45
Q2 25
$-0.03
$-0.04
Q1 25
$-0.04
$1.24
Q4 24
$-0.12
$0.51
Q3 24
$-0.06
$-1.17
Q2 24
$0.00
$-5.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
CORZ
CORZ
Cash + ST InvestmentsLiquidity on hand
$307.8M
$311.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-962.7M
Total Assets
$645.8M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
CORZ
CORZ
Q1 26
$307.8M
Q4 25
$302.6M
$311.4M
Q3 25
$286.6M
$453.4M
Q2 25
$298.7M
$581.3M
Q1 25
$281.8M
$697.9M
Q4 24
$294.2M
$836.2M
Q3 24
$305.7M
$253.0M
Q2 24
$306.7M
$96.1M
Stockholders' Equity
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
$459.3M
$-962.7M
Q3 25
$458.9M
$-1.3B
Q2 25
$464.9M
$-1.2B
Q1 25
$473.7M
$-308.8M
Q4 24
$486.2M
$-943.0M
Q3 24
$531.4M
$-826.7M
Q2 24
$551.9M
$-1.2B
Total Assets
AMRN
AMRN
CORZ
CORZ
Q1 26
$645.8M
Q4 25
$670.8M
$2.3B
Q3 25
$659.8M
$2.2B
Q2 25
$670.1M
$1.9B
Q1 25
$655.7M
$1.5B
Q4 24
$685.3M
$1.5B
Q3 24
$750.6M
$824.6M
Q2 24
$799.9M
$664.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
CORZ
CORZ
Operating Cash FlowLast quarter
$278.3M
Free Cash FlowOCF − Capex
$-450.8M
FCF MarginFCF / Revenue
-565.1%
Capex IntensityCapex / Revenue
914.0%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$-779.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
$15.3M
$278.3M
Q3 25
$-12.7M
$131.8M
Q2 25
$16.6M
$34.0M
Q1 25
$-12.5M
$-45.0M
Q4 24
$-13.3M
$42.9M
Q3 24
$-2.4M
$5.7M
Q2 24
$-2.7M
$1.2M
Free Cash Flow
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
$-450.8M
Q3 25
$-112.7M
Q2 25
$-87.3M
Q1 25
$-129.0M
Q4 24
$-52.1M
Q3 24
$-25.5M
Q2 24
$-1.9M
FCF Margin
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
-565.1%
Q3 25
-139.0%
Q2 25
-111.0%
Q1 25
-162.2%
Q4 24
-54.8%
Q3 24
-26.7%
Q2 24
-1.4%
Capex Intensity
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
914.0%
Q3 25
301.5%
Q2 25
154.2%
Q1 25
105.6%
Q4 24
100.0%
Q3 24
32.7%
Q2 24
2.2%
Cash Conversion
AMRN
AMRN
CORZ
CORZ
Q1 26
Q4 25
1.30×
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

CORZ
CORZ

Other$36.3M46%
Digital Asset Self Mining Service$31.8M40%
Colocation Service$11.6M15%

Related Comparisons